Trial intelligence / Profile preview

Dexmedetomidine for POCD in Cardiac Surgery

NCT03054857Phase 4Completed

Sponsor
Chulalongkorn University
Start
Jun 2015
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Dex group with Placebo group (2 arms). Primary endpoint: Postoperative Cognitive Dysfunction at 7 days. Started Jun 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT03054857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03054857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call